相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Growth hormone and prolactin-staining tumors causing acromegaly: a retrospective review of clinical presentations and surgical outcomes
Jonathan Rick et al.
JOURNAL OF NEUROSURGERY (2019)
An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors
Omalkhaire M. Alshaikh et al.
ENDOCRINE PATHOLOGY (2019)
PREDICTIVE MARKERS FOR POSTSURGICAL MEDICAL MANAGEMENT OF ACROMEGALY: A SYSTEMATIC REVIEW AND CONSENSUS TREATMENT GUIDELINE
Shereen Ezzat et al.
ENDOCRINE PRACTICE (2019)
GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors
Ozgur Mete et al.
MODERN PATHOLOGY (2019)
Mammosomatotroph and mixed somatotroph-lactotroph adenoma in acromegaly: a retrospective study with long-term follow-up
Liang Lv et al.
ENDOCRINE (2019)
Growth hormone-producing pituitary adenomas in childhood and young adulthood: clinical features and outcomes
Yuichi Nagata et al.
PITUITARY (2018)
Epidemiology and biomarker profile of pituitary adenohypophysial tumors
Ozgur Mete et al.
MODERN PATHOLOGY (2018)
Pathology of GH-producing pituitary adenomas and GH cell hyperplasia of the pituitary
Luis V. Syro et al.
PITUITARY (2017)
Pituitary acromegaly: not one disease
Sylvia L. Asa et al.
ENDOCRINE-RELATED CANCER (2017)
Overview of the 2017 WHO Classification of Pituitary Tumors
Ozgur Mete et al.
ENDOCRINE PATHOLOGY (2017)
Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study
Donato Iacovazzo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics
Marie Helene Schernthaner-Reiter et al.
NEUROENDOCRINOLOGY (2016)
T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly
Iulia Potorac et al.
ENDOCRINE-RELATED CANCER (2016)
Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas
Ozgur Mete et al.
MODERN PATHOLOGY (2016)
Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study
Donato Iacovazzo et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)
Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly
Ansgar Heck et al.
ENDOCRINE (2016)
Aggressive Pituitary Tumors or Localized Pituitary Carcinomas: Defining Pituitary Tumors
Sylvia L. Asa et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2016)
A Structural and Functional Acromegaly Classification
Daniel Cuevas-Ramos et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Differential somatostatin receptor (SSTR) 1-5 expression and downstream effectors in histologic subtypes of growth hormone pituitary tumors
Katja Kiseljak-Vassiliades et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype
Cheng-Chia Lee et al.
PITUITARY (2015)
Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas
Judit Denes et al.
PLOS ONE (2015)
Growth hormone tumor histological subtypes predict response to surgical and medical therapy
Katja Kiseljak-Vassiliades et al.
ENDOCRINE (2015)
Acromegaly and McCune-Albright Syndrome
Sylvie Salenave et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation
G. Trivellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas
Sarah Larkin et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Molecular and functional properties of densely and sparsely granulated GH-producing pituitary adenomas
Bernhard Mayr et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Growth hormone-releasing hormone-producing pancreatic neuroendocrine tumor in a multiple endocrine neoplasia type 1 family with an uncommon phenotype
Elisa Sala et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2013)
Growth hormone granulation pattern and somatostatin receptor subtype 2A correlate with postoperative somatostatin receptor ligand response in acromegaly: a large single center experience
Jessica Brzana et al.
PITUITARY (2013)
Acromegaly induced by ectopic secretion of GHRH: A review 30 years after GHRH discovery
Francoise Borson-Chazot et al.
ANNALES D ENDOCRINOLOGIE (2012)
Adenoma granulation pattern correlates with clinical variables and effect of somatostatin analogue treatment in a large series of patients with acromegaly
Stine Lyngvi Fougner et al.
CLINICAL ENDOCRINOLOGY (2012)
Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly
Ansgar Heck et al.
CLINICAL ENDOCRINOLOGY (2012)
Differential expression of genes related to drug responsiveness between sparsely and densely granulated somatotroph adenomas
Masako Kato et al.
ENDOCRINE JOURNAL (2012)
Clinical Characteristics and Outcome of Acromegaly Induced by Ectopic Secretion of Growth Hormone-Releasing Hormone (GHRH): A French Nationwide Series of 21 Cases
Laetitia Garby et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Familial isolated pituitary adenomas: An emerging clinical entity
F. Martucci et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2012)
The changing face of acromegaly-advances in diagnosis and treatment
Antonio Ribeiro-Oliveira et al.
NATURE REVIEWS ENDOCRINOLOGY (2012)
Pituitary Carcinoma with Malignant Growth from First Presentation and Fulminant Clinical Course-Case Report and Review of the Literature
Katarzyna Dudziak et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Place of Cabergoline in Acromegaly: A Meta-Analysis
Laure Sandret et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Growth hormone-secreting pituitary adenomas From molecular basis to treatment options in acromegaly
Simone Magnavita Sabino et al.
CANCER BIOLOGY & THERAPY (2010)
Relationship between cytokeratin staining patterns and clinico-pathological features in somatotropinomae
Yuriz Bakhtiar et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Growth hormone-secreting adenomas: pathology and cell biology
M. Beatriz S. Lopes
NEUROSURGICAL FOCUS (2010)
The Pathogenesis of Pituitary Tumors
Sylvia L. Asa et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Gangliocytomas of the sellar region — a review
M. J. A. Puchner et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2009)
Medical Therapy in Patients with Acromegaly: Predictors of Response and Comparison of Efficacy of Dopamine Agonists and Somatostatin Analogues
M. Sherlock et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): A case-control study in a series of 77 patients versus 2509 non-MEN1 patients
Jacqueline Trouillas et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Clinicopathological features of growth hormone-producing pituitary adenomas: Difference among various types defined by cytokeratin distribution pattern including a transitional form
Abdulkader Obari et al.
ENDOCRINE PATHOLOGY (2008)
The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas
Chrysanthia A. Leontiou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors
Sylvia L. Asa et al.
CANCER RESEARCH (2007)
Medical progress: Acromegaly
Shlomo Melmed
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma
Christian Nasr et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
KE O'Reilly et al.
CANCER RESEARCH (2006)
Pathology of acromegaly
Eva Horvath et al.
NEUROENDOCRINOLOGY (2006)
The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly
S Bhayana et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: Imaging characteristics and pathologic correlation
A Hagiwara et al.
RADIOLOGY (2003)
Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies
B Xu et al.
ENDOCRINE PATHOLOGY (2002)
SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile
C Bruns et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
Growth hormone-secreting pituitary adenoma confined to the sphenoid sinus associated with a normal-sized empty sella
E Hori et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2002)
Pituitary carcinoma as a cause of acromegaly
CW le Roux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Growth hormone-releasing hormone (GHRH) and GHRH receptor (GHRH-R) isoform expression in ectopic acromegaly
NH Othman et al.
CLINICAL ENDOCRINOLOGY (2001)
Acromegaly caused by secretion of growth hormone by a non-Hodgkin's lymphoma.
F Beuschlein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
